97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details

臨床試験数 : 2,527 / 薬物数 : 1,465 - (DrugBank : 259) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

8 trials found

diseases per page:

Showing 1 to 8 of 8 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2010-023762-49-BE (EUCTR)	23/04/2012	21/11/2011	A study to evaluate the safety and how anrukinzumab(IMA-638) works in the body for patients with Ulc ...	A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, SPONSOR UNBLINDED, PLACEBO-CONTROLLED, MULTIPLE DOSE STUDY TO ...	Ulcerative Colitis MedDRA version: 14.0;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Not Applicable Product Code: PF-05230917 INN or Proposed INN: Not Applicable Other descri ...	Pfizer Inc., 235 East 42nd Street, New York, NY 10017	NULL	Not Recruiting			Female: yes Male: yes	80	Phase 2	United States;France;Hungary;Canada;Spain;Poland;Belgium;Romania;Austria;Bulgaria;Germany;Netherland ...
2	EUCTR2010-023762-49-PL (EUCTR)	06/01/2012	05/07/2011	A study to evaluate the safety and how anrukinzumab(IMA-638) works in the body for patients with Ulc ...	A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, SPONSOR UNBLINDED, PLACEBO-CONTROLLED, MULTIPLE DOSE STUDY TO ...	Ulcerative Colitis MedDRA version: 14.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Not Applicable Product Code: PF-05230917 INN or Proposed INN: Not Applicable Other descri ...	Pfizer Inc., 235 East 42nd Street, New York, NY 10017	NULL	Not Recruiting			Female: yes Male: yes	80	Phase 2	United States;France;Hungary;Canada;Spain;Belgium;Poland;Romania;Austria;Bulgaria;Germany;Netherland ...
3	EUCTR2010-023762-49-DE (EUCTR)	29/11/2011	17/08/2011	A study to evaluate the safety and how anrukinzumab(IMA-638) works in the body for patients with Ulc ...	A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, SPONSOR UNBLINDED, PLACEBO-CONTROLLED, MULTIPLE DOSE STUDY TO ...	Ulcerative Colitis MedDRA version: 17.0;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Not Applicable Product Code: PF-05230917 INN or Proposed INN: Not Applicable Other descri ...	Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA	NULL	Not Recruiting			Female: yes Male: yes	80	Phase 2	France;United States;Hungary;Canada;Poland;Belgium;Spain;Romania;Austria;Bulgaria;Netherlands;German ...
4	EUCTR2010-023762-49-HU (EUCTR)	09/11/2011	13/05/2011	A study to evaluate the safety and how anrukinzumab(IMA-638) works in the body for patients with Ulc ...	A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, SPONSOR UNBLINDED, PLACEBO-CONTROLLED, MULTIPLE DOSE STUDY TO ...	Ulcerative Colitis MedDRA version: 14.0;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Not Applicable Product Code: PF-05230917 INN or Proposed INN: Not Applicable Other descri ...	Pfizer Inc., 235 East 42nd Street, New York, NY 10017	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	80	Phase 2	Hungary;Germany;Canada;Netherlands;Belgium;Romania;France;Bulgaria;Spain;United States;Poland;Austri ...
5	EUCTR2010-023762-49-AT (EUCTR)	22/07/2011	26/04/2011	A study to evaluate the safety and how anrukinzumab(IMA-638) works in the body for patients with Ulc ...	A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, SPONSOR UNBLINDED, PLACEBO-CONTROLLED, MULTIPLE DOSE STUDY TO ...	Ulcerative Colitis MedDRA version: 14.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Not Applicable Product Code: PF-05230917 INN or Proposed INN: Not Applicable Other descri ...	Pfizer Inc., 235 East 42nd Street, New York, NY 10017	NULL	Not Recruiting			Female: yes Male: yes	80	Phase 2	France;United States;Hungary;Canada;Belgium;Spain;Poland;Romania;Austria;Bulgaria;Germany;Netherland ...
6	EUCTR2010-023762-49-BG (EUCTR)	06/06/2011	31/05/2011	A study to evaluate the safety and how anrukinzumab(IMA-638) works in the body for patients with Ulc ...	A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, SPONSOR UNBLINDED, PLACEBO-CONTROLLED, MULTIPLE DOSE STUDY TO ...	Ulcerative Colitis MedDRA version: 15.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Not Applicable Product Code: PF-05230917 INN or Proposed INN: Not Applicable Other descri ...	Pfizer Inc., 235 East 42nd Street, New York, NY 10017	NULL	Not Recruiting			Female: yes Male: yes	80	Phase 2	France;United States;Hungary;Canada;Belgium;Spain;Poland;Romania;Austria;Bulgaria;Germany;Netherland ...
7	EUCTR2010-023762-49-ES (EUCTR)	16/05/2011	11/02/2011	ESTUDIO EN FASE 2A, ALEATORIZADO, DOBLE CIEGO, SIN ENMASCARAMIENTO PARA EL PROMOTOR, CONTROLADO CON ...	ESTUDIO EN FASE 2A, ALEATORIZADO, DOBLE CIEGO, SIN ENMASCARAMIENTO PARA EL PROMOTOR, CONTROLADO CON ...	Colitis ulcerosa MedDRA version: 12.1;Level: LLT;Classification code 10045365;Term: Ulcerative colit ...	Product Name: Not Applicable Product Code: PF-05230917 INN or Proposed INN: Not Applicable Other descri ...	Pfizer, S.L.U.	NULL	Not Recruiting			Female: yes Male: yes	80	Phase 2	Hungary;Belgium;Poland;Spain;Bulgaria;Germany
8	NCT01284062 (ClinicalTrials.gov)	March 2011	25/1/2011	Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients	A Phase 2a, Randomized, Double-blind, Sponsor Unblinded, Placebo-controlled, Multiple Dose Study To ...	Colitis, Ulcerative	Biological: Anrukinzumab;Other: placebo	Pfizer	NULL	Completed	18 Years	65 Years	All	84	Phase 2	United States;Austria;Bulgaria;Canada;France;Germany;Hungary;Netherlands;Poland;Romania;Spain;Belgiu ...

First Previous1Next Last